|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS: | ||||||||||||||||||||
| Noninterest-bearing balances | ||||||||||||||||||||
| Interest-bearing balances in other financial institutions | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Investment debt securities, available for sale, at fair value | ||||||||||||||||||||
| Investment equity securities, at fair value | ||||||||||||||||||||
| Restricted investment in bank stock | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Loans, net | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Investment in limited partnerships | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangibles | ||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Interest-bearing deposits | ||||||||||||||||||||
| Noninterest-bearing deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Long-term borrowings | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| SHAREHOLDERS’ EQUITY: | ||||||||||||||||||||
| Preferred stock, no par value, 3,000,000 shares authorized; no shares issued | ||||||||||||||||||||
| Common stock, par value $5.55, 22,500,000 shares authorized; 8,124,439 and 8,066,968 shares issued; 7,614,214 and 7,556,743 outstanding | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss: | ||||||||||||||||||||
| Net unrealized loss on available for sale securities | ||||||||||||||||||||
| Defined benefit plan | ||||||||||||||||||||
| Treasury stock at cost, 510,225 shares | ||||||||||||||||||||
| Treasury stock at cost, 510,225 shares | ||||||||||||||||||||
| TOTAL SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Treasury stock (in shares) | ||||||||||||||||||||
Loading...
